ANEMIA IN CHRONIC KIDNEY DISEASE PATIENTS IN BRAZIL
Abstract
Chronic Kidney Disease (CKD) is a term used to describe conditions characterized by diverse changes affecting kidney structure and function. It can lead to multiple complications associated with kidney failure, including anemia, which can manifest even in the early stages of kidney dysfunction. The objective of this study was to explore the topic of anemia in patients with chronic kidney disease in Brazil. The research consists of a systematic review conducted between March and April 2026, based on a search of articles in the literature found in the following databases: Scielo, PubMed, and LILACS, using search terms such as “Anemia”, “Kidney Disease”, “Chronicity”, “Dialysis”, “Brazil”, “Anemia”, “Doença Renal”, “Cronicidade”, “Diálise” and “Brasil”. A total of 219 articles were identified based on the criteria applied in the methodology described, and 12 articles were selected for inclusion in this integrative review. Anemia in patients with chronic kidney disease (CKD) is a serious public health problem due to increased rates of morbidity and mortality. To minimize the impact on patients’ quality of life and the development of secondary conditions, the glomerular filtration rate (GFR) and the use of erythropoietin for treating this type of anemia must be taken into account. The development of measures aimed at early diagnosis, effective therapeutic resources, and professional training can contribute to reducing complications related to CKD associated with anemia in Brazil.
Author Biographies
Undergraduate student at Centro Universitário Florence.
PhD, Centro Universitário Florence.
References
BRASIL. Ministério da Saúde. Portaria nº 365, de 15 de fevereiro de 2017. Aprova o Protocolo Clínico e Diretrizes Terapêuticas - Anemia na Doença Renal Crônica. Brasília, DF: Ministério da Saúde, 2017.
BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde e Ambiente. Cenário da Doença Renal Crônica no Brasil no período de 2010 a 2023. Boletim Epidemiológico, Brasília, v. 55, n. 12, p. 1-20, 2024.
BRITO, M.; EDUARDO, J. M. Anemia na doença renal crônica: impacto e estratégias de manejo. Hematology, Transfusion and Cell Therapy, v. 47, supl. 3, 2025.
CASES, Aleix et al. Anemia en la enfermedad renal crónica: protocolo de estudio, manejo y derivación a Nefrología. Atención Primaria, v. 50, n. 1, p. 60-64, 2018.
CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC). Chronic Kidney Disease in the United States. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2026.
DRAIBE, Sérgio Antônio et al. Panorama da Doença Renal Crônica no Brasil e no mundo. UNASUS/UFMA. São Luís, 2016.
FARRELL, Douglas R.; VASSALOTTI, Joseph A. Screening, identifying, and treating chronic kidney disease: why, who, when, how, and what? BMC Nephrology, Londres, v. 25, n. 34, p. 1-13, 2024.
GIASSI, Karina; PIZZOLATTI, Romulo Cézar. Anemia da doença renal crônica: perfil epidemiológico dos pacientes em hemodiálise em uso de eritropoetina no ano de 2012 na cidade de Criciúma. Arquivos Catarinenses de Medicina, v. 44, n. 2, p. 2-12, 2016.
HONDA, Hirokazu et al. Iron metabolism in chronic kidney disease patients. In: CKD-Associated Complications: Progress in the Last Half Century. Karger Publishers, p. 103-111. 2019.
KDIGO. KDIGO 2025 Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney International, v. 107, supl. 2S, p. S1-S239, 2025.
KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International, v. 105, supl. 4S, p. S117-S314, 2024.
MIKHAIL, Ashraf et al. Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease. BMC nephrology, v. 18, n. 1, p. 1-29, 2017.
NERBASS, Fabiana Baggio et al. Censo Brasileiro de Diálise 2022. Brazilian Journal of Nephrology, v. 46, n. 2, e20230062, 2024.
PORTOLÉS, J. et al. Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents. Frontiers in Medicine, v. 8, p. 642296, 2021.
SAWA, Jun et al. Effects of darbepoetin alfa and epoetin beta pegol on iron kinetics in hemodialysis patients. Renal Replacement Therapy, Londres, v. 2, n. 26, p. 1-7, 2016.
SPINOWITZ, Bruce et al. Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review. Journal of Medical Economics, v. 22, n. 6, p. 593-604, 2019.
WONG, Michelle MY et al. Anemia and iron deficiency among chronic kidney disease Stages 3–5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably treated. Clinical kidney journal, v. 13, n. 4, p. 613-624, 2020.
ZICA, C. L. A., Oliveira, T. S., de Gouveia, I. P. P., de Oliveira, R. R., & de Oliveira Vasconcelos, M. Anemia de doença crônica na doença renal crônica. Conexão Ci, Formiga/MG, Vol. 14, N. 2, p.57-65, 2019.
License
Copyright (c) 2026 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218
This work is licensed under a Creative Commons Attribution 4.0 International License.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.